Pharmafile Logo
Pharmafocus logo
Advanced Search

Oxford BioMedica fills leadership vacancy

October 14, 2008
Research and Development, Sales and Marketing biotech

Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …

News
EFPIAcropped

Pharma prepares for battle over EU patient information

October 14, 2008
Sales and Marketing EU, patients, reform

 A collective of European legislators, patient groups and the pharma industry have reiterated the call for Europe’s ban on pharma …

News

Johnson & Johnson appoints new global pharma chair

October 14, 2008
Sales and Marketing JJ

Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …

News

Working Life: Dr Zubair Hussain

October 13, 2008
Business Services, Research and Development, Sales and Marketing Pfizer, UK, careers, recruitment, reg affairs

How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …

Feature

Latest news from Datamonitor

October 13, 2008
Sales and Marketing HIV

Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …

News

The Pharmafocus Interview: Jan Lundberg

October 10, 2008
Research and Development AstraZeneca, clinical trials, drug discover

AstraZeneca's head of global drug discovery Jan Lundberg says his younger years as a sportsman have made him a determined …

Feature

Novartis pursues pulmonary hypertension indication for Glivec

October 10, 2008
Sales and Marketing

Novartis says new data on Glivec shows it has potential to treat a life-threatening heart condition, despite failing to meet …

News

England’s mental health policy leading Europe, says WHO

October 10, 2008
NHS, mental health

A new report from the World Health Organisation says England's mental health care has undergone a 'transformation' in the last …

News

A postcard from … Slovakia

October 10, 2008
Research and Development, Sales and Marketing Europe, Slovakia, hc

Feature

UK is example to Europe on patient information, says industry

October 9, 2008
Medical Communications patients

British pharma is free to provide necessary and sufficient information to patients about its drugs, and an example to be …

News

Lilly eyes oncology focus with ImClone acquisition

October 9, 2008
Sales and Marketing Cancer, MA, lilly

Lilly is to buy ImClone for $6.5 billion after outbidding Bristol-Myers Squibb for the biotech company. Lilly says the acquisition …

News

GlycArt’s new cancer candidate to be developed with Roche

October 9, 2008
Research and Development, Sales and Marketing GlycArt, Roche

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …

News

Advertising start-up is UK’s ‘first virtual healthcare agency’

October 7, 2008
Medical Communications digi

A new advertising agency has been launched as the UK’s first ‘virtual’ healthcare outfit, and aims to undercut traditional agencies …

News

Norgine quits ABPI and denounces big pharma bias

October 6, 2008
Sales and Marketing ABPI, Norgine

News

Latest news from Datamonitor

October 6, 2008
Sales and Marketing OTC

Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs? The growing cost of developing …

News

GSK plans research job losses in UK

October 3, 2008
Research and Development GSK, restructure

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

News

Emerging confidence

October 2, 2008
Research and Development, Sales and Marketing emerging markets, evidence-based medicine

 The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …

Feature

Osteoporosis drug Aclasta approved for use in men

October 2, 2008
Sales and Marketing Novartis, aclasta, osteoporosis

Osteoporosis treatment Aclasta has been approved for an extended indication in the European Union.Novartis’ once-yearly infusion has now been given …

News

Long-acting Zyprexa gets green light

October 2, 2008
Sales and Marketing lilly, psych

Lilly's Zypadhera has been recommended in Europe for use in stabilising schizophrenic patients who are already receiving treatment. The European …

News

Spiriva partners defend drug’s safety

October 2, 2008
Sales and Marketing Boehringer, COPD, Spiriva, resp

Boehringer Ingelheim and Pfizer have released new data on Spiriva to defend the safety record of the chronic obstructive pulmonary …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026